This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Mereo Biopharma 1 Limited. Active years: 2021-2022.
Company Filing History:
Years Active: 2021-2022
Title: Stewart Jones: Innovator in Pharmaceutical Chemistry
Introduction
Stewart Jones is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work focuses on the development of innovative methods for producing polymorphic forms of specific compounds.
Latest Patents
Among his latest patents, Stewart has developed a method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide. This invention relates to a process for the preparation of Form A of the compound, which includes pharmaceutical compositions obtainable by the described process. Additionally, he has patented another method for producing a polymorphic form of the same compound, specifically Form B, which also includes pharmaceutical compositions derived from this process.
Career Highlights
Stewart Jones is currently associated with Mereo Biopharma Limited, where he continues to advance his research and development efforts. His expertise in pharmaceutical formulations has positioned him as a valuable asset in the industry.
Collaborations
Stewart collaborates with talented professionals such as Osama Suleiman and Lucia Romero Perez, contributing to a dynamic research environment.
Conclusion
Stewart Jones exemplifies innovation in pharmaceutical chemistry through his patented methods and collaborative efforts. His work continues to impact the field positively, showcasing the importance of research and development in creating effective pharmaceutical solutions.